|
|
Volumn 39, Issue 4 II, 2004, Pages 1119-1122
|
|
Commentary - Current MSA theory: Well-meaning but futile
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIASTHMATIC AGENT;
ANTIHYPERTENSIVE AGENT;
CHRONIC DISEASE;
CONFERENCE PAPER;
COST BENEFIT ANALYSIS;
ECONOMIC ASPECT;
HEALTH CARE COST;
HEALTH CARE PLANNING;
HEALTH CARE SYSTEM;
HEALTH INSURANCE;
HOSPITAL CARE;
HUMAN;
PRESCRIPTION;
THEORY;
|
|
EID: 3142742331
PISSN: 00179124
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1475-6773.2004.00277.x Document Type: Conference Paper |
|
Times cited : (13)
|
|
References (0)
|